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Background: Leptospirosis is a zoonose that is increasingly endemic in built-up areas, especially where there are
communities living in precarious housing with poor or non-existent sanitation infrastructure. Leptospirosis can kill,
for its symptoms are easily confused with those of other diseases. As such, a rapid diagnosis is required so it can be
treated effectively. A test for leptospirosis diagnosis using Leptospira Immunoglobulin-like (Lig) proteins is currently
at final validation at Fiocruz.
Results: In this work, the process for expression of LigB (131-645aa) in E. coli BL21 (DE3)Star™/pAE was evaluated.
No significant difference was found for the experiments at two different pre-induction temperatures (28°C and
37°C). Then, the strain was cultivated at 37°C until IPTG addition, followed by induction at 28°C, thereby reducing
the overall process time. Under this condition, expression was assessed using central composite design for two
variables: cell growth at which LigB (131-645aa) was induced (absorbance at 600 nm between 0.75 and 2.0) and
inducer concentration (0.1 mM to 1 mM IPTG). Both variables influenced cell growth and protein expression. Induction
at the final exponential growth phase in shaking flasks with Absind = 2.0 yielded higher cell concentrations and
LigB (131-645aa) productivities. IPTG concentration had a negative effect and could be ten-fold lower than the concentration
commonly used in molecular biology (1 mM), while keeping expression at similar levels and inducing less damage
to cell growth. The expression of LigB (131-645aa) was associated with cell growth. The induction at the end of the
exponential phase using 0.1 mM IPTG at 28°C for 4 h was also performed in microbioreactors, reaching higher cell
densities and 970 mg/L protein. LigB (131-645aa) was purified by nickel affinity chromatography with 91% homogeneity.
Conclusions: It was possible to assess the effects and interactions of the induction variables on the expression of soluble
LigB (131-645aa) using experimental design, with a view to improving process productivity and reducing the production
costs of a rapid test for leptospirosis diagnosis.
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Leptospirosis is a zoonotic disease caused by spirochetes
of the genus Leptospira that occurs in tropical, subtrop-
ical and temperate climates. It is an increasing problem
in cities, particularly as people migrate from poor, rural
areas to towns, where they often end up living in poor
housing conditions with limited or no sanitation infra-
structure, resulting in a change in the epidemiological
profile of the disease. Infection occurs during exposure
to animal reservoirs or environments contaminated with
urine. The most widespread source of infection is due to
rodents that carry the Leptospira in their kidneys and
eliminate it in their urine, contaminating water, soil and
foodstuffs. Leptospirosis produces a variety of clinical
manifestations ranging from an undifferentiated febrile
illness to severe forms such as Weil’s disease and pul-
monary hemorrhage syndrome, for which mortality is
5% to 40% [1-4].
Leptospirosis has become a major public health issue,
demanding increased investments in housing conditions
and especially the development of rapid diagnosis and
directed treatment methods. Prompt diagnosis is critical
in preventing severe outcomes, since antibiotics are be-
lieved to provide the greatest benefit when initiated early
in the course of the illness. Early phase leptospirosis is
often missed or else is misdiagnosed and put down to
some other cause of acute febrile disease because of its
non-specific clinical presentation. The identification of
leptospirosis depends on high clinical suspicion and ef-
fective laboratory tests [1,2]. The standard diagnostic
assay (Microscopic Agglutination Test, MAT) requires
paired serum samples for proper interpretation and is
not adequate for clinical decision-making. Recent evalu-
ation found that commercial whole Leptospira-based
assays such as ELISAs and other rapid formats had 29-
52% sensitivity and 85-100% specificity, and the sensitiv-
ity for these assays was below 25% for patients in the
first week of illness [5]. PCR-based detection methods
have been restricted to the reference laboratory setting
and are unlikely to be implemented in developing coun-
tries, which shoulder the greatest public health burden
of leptospirosis [1,5]. Therefore, it is ever more urgent
that new strategies for diagnosis be developed and new
diagnostic markers be identified, which can aid early
case identification and timely administration of anti-
biotic therapy.
The urgent need for intervention at the early stages of
the disease has led several different groups to join forces
in developing a new generation of diagnostic reagents to
improve and accelerate the identification of cases and
consequently bring forward the start of antimicrobial
therapy. Researchers from Fiocruz (Bio-Manguinhos/Rio
de Janeiro and CPqGM/Bahia) are developing a rapid
serodiagnostic test for leptospirosis based on the DualPath Platform (DPP®) Technology from Chembio, which
is crucially important for leptospirosis detection so treat-
ment can be started promptly under the Brazilian public
health system. The rapid test result is given in just 15 mi-
nutes. It uses a drop of blood from individuals suspected
of having the illness, and is easy to handle and with
diagnostic accuracy similar to currently used assays [6].
The test is based on antigen-antibody reaction with sera
of leptospirosis patients, which reacts with immunodo-
minant proteins of the bacteria. The proteins expressed
during host infection are expected to elicit a specific
antibody response, and may therefore serve as candidate
serodiagnostic markers [5,6].
In order to develop this diagnostic kit, targets from
the genome of L. interrogans serovar Copenhageni [7,8]
were selected and a novel protein family was identified,
named Leptospira Immunoglobulin-like proteins (Lig):
LigA, LigB and LigC. Lig proteins are Microbial Surface
Components Recognizing Adhesive Matrix Molecules
(MSCRAMMs), in that they have the ability to bind
to fibronectin, laminin, collagen, fibrinogen, elastin, and
tropoelastin in host cells, and also binding several com-
plement components and complement regulator pro-
teins [9-13]. A recent study [13] proposed that LigB has
other activities suggesting its importance early in infec-
tion, including binding extracellular matrix, plasma, and
cutaneous repair proteins and inhibiting hemostasis.
LigA and LigB both have an identical region called
LigB (131-645aa), which is made up of seven repeated
domains present in both proteins (Figure 1). The Lig
proteins are conserved between pathogenic leptospires
and can be used as candidate serodiagnostic markers for
leptospirosis at its acute phase; for this reason they have
been used in the development of assays for leptospirosis
diagnosis. Previous data showed that sera from patients
identified during urban outbreaks in Brazil reacted
strongly with immunoblots of a recombinant fragment
of LigB (131-645aa) from L. interrogans serovar
Copenhageni and a LigB analogous fragment derived
from L. kirschneri serovar Grippotyphosa [5]. Another
study showed 92% sensitivity with sera in the acute
phase and specificity ranged from 86 to 100% among
sera from healthy individuals from endemic area and
from patients diagnosed with others diseases with clin-
ical signs that overlap with leptospirosis [6]. These
findings indicate that the antibody response to this
putative virulence determinant is a sensitive and specific
marker for acute infection. Therefore, the protein
LigB (131-645aa) was selected as a promising candidate to
compose the new rapid diagnostic test for leptospirosis [5,6].
So as to obtain these proteins on a large enough scale
for the widespread use of the rapid diagnostic test for
leptospirosis, LigB (131-645aa) protein was cloned in
plasmid pAE with a T7 promoter induced by isopropyl
Figure 1 Scheme of LigA and LigB proteins from L. interrogans serovar Copenhageni adapted from Silva et al. [17]. The squares
represent the immunoblobulin-like repeat domains found in the proteins of Leptospira. The C-terminal portion of the LigB protein is represented
by the final rectangle. LigA (1224 amino acids and 128 kDa) and LigB (1891 amino acids and 201 kDa) present a region with seven repeated
identical domains named LigB (131-645aa) (corresponding to amino acids 131 to 645 of LigA and LigB with 54 kDa, indicated by grey squares).
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coli as the host because of its capacity to grow fast in
high cell concentrations and in cheap, relatively simple
cultures. In order to take advantage of the flexibility of
inducible promoter systems, the optimal point in E. coli
growth for inducing the expression of the recombinant
protein and the optimal inducer concentration should be
determined [14]. Nevertheless, the most common strat-
egy employed in molecular biology is still to evaluate the
influence of such variables on heterologous protein ex-
pression by changing one factor at a time while holding
the others constant, assuming that each variable is inde-
pendent. This assumption is usually too simplistic when
considering complex biological systems and is not effi-
cient in many cases because it does not enable the inter-
action between variables to be analyzed. Experimental
design techniques were developed to enable the max-
imum information about the process using as few exper-
iments as possible [15].
As such, the expression of the recombinant protein
LigB (131-645aa) from E. coli was assessed in shaking
flasks, using central composite design (CCD) for two
variables: cell growth for the induction of protein ex-
pression, and the inducer concentration to be used in
the recombinant system (IPTG). The conditions were
confirmed in a microbioreactor and resulted in high
density cell growth and protein expression.
Methods
Strain used
E. coli BL21 (DE3) Star™ (Invitrogen) was the bacterium
used to express the recombinant protein LigB (131-645aa)
from L. interrogans serovar Copenhageni (54 kDa) cloned
in the vector pAE [16,17].
Chemicals
Bacto™ yeast extract and tryptone were purchased from
BD (Becton, Dickinson and Company); the potassium salts
(K2HPO4 and KH2PO4), glucose and NaCl came from
Merck; the glycerol was from Invitrogen; the ampicillinwas from Sigma; and IPTG (isopropyl β-D-1-thiogalacto-
pyranoside) was from Promega.Cell viability test
The cell viability of the stock of recombinant E. coli BL21
(DE3) Star™/pAE/LigB (131-645aa) in LB (5 g/L yeast
extract, 10 g/L tryptone, 10 g/L NaCl, pH 7.0) with 25%
glycerol, stored at -70°C, was assessed by counting colony
forming units (CFU’s). Serial dilutions were made in PBS,
pH 7.4, and transferred to Petri dishes containing LB Agar
and 100 μg/mL ampicillin. Cell concentrations of stocks
were obtained around 3.5 × 1010 CFU/mL, with 20% error.Evaluation of pre-induction temperature
The recombinant bacteria E. coli BL21 (DE3) Star™/pAE/
LigB (131-645aa) were cultivated (10 μL) in 10 mL TB
medium supplemented with 1% glucose, 0.4% glycerol and
100 μg/mL ampicillin in 50 mL flasks agitated at 200 rpm,
at 28°C and 37°C, with samples being taken at 30-minute
intervals to measure growth by absorbance at 600 nm. At
both temperatures, LigB (131-645aa) expression was
induced at Absind = 0.75 with 0.55 mM IPTG, with data
being taken hourly to assess cell growth, specific growth
rates and recombinant protein expression, for the purposes
of comparison with the curves without induction.Calculation of specific growth rates
The specific growth rates (μ) were calculated using the
cell mass balance equation for batch processes: dXdt ¼ X μ
When this equation is integrated from X0 (initial cell
concentration) to X and from t = 0 to t, it gives:
X = X0 e
μ ⋅ t and ln(X/X0) = μ t. Using this equation, and
taking X as the absorbance measurements at 600 nm,
linear adjustments were made to the plots during the
exponential growth phase prior to induction, and of
growth after IPTG addition. The specific growth rates
were obtained with the linear correlation coefficient (R2)
at around 0.99.
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induction (Absind) and IPTG concentration
Inoculum: 10 μL of the E. coli BL21 (DE3) Star™/pAE/
LigB (131-645aa) stock was pre-inoculated in 10 mL TB
medium (23.6 g/L yeast extract, 11.8 g/L tryptone,
9.4 g/L K2HPO4, and 2.2 g/L KH2PO4, pH 7.2) enriched
with 1% glucose, 0.4% glycerol and 100 μg/mL ampicil-
lin for 16 h at 37°C and 200 rpm, in shaking 50 mL
flasks.
Growth: 2 mL of the inoculum saturated was grown in
100 mL of the same medium (resulting in initial absorb-
ance at 600 nm of around 0.1), in 500 mL flasks at 37°C
and 200 rpm. Cells were left to grow until the desired
conditions were reached for the recombinant protein to
be induced with IPTG.
Induction: induction with IPTG was conducted at 28°C
and 200 rpm for 4 h, varying the cell growth by absorbance
measurements at 600 nm (Absind) of between 0.75 and 2.0,
and varying the inducer concentration between 0.1 mM
and 1.0 mM IPTG, using central composite design for
these two variables, with triplicate runs at the central point
(Absind 1.4 and 0.55 mM IPTG). The means ± standard
deviation at the central point were calculated for each re-
sponse analyzed (cell growth, LigB (131-645aa) expression,
glucose and pH).
Assessment of cell growth and determination of the dry
mass of cells
After 4 h induction, cell growth was measured by absorb-
ance at 600 nm. Cell pellets were obtained from 25 mL
culture after centrifugation at 3220 × g for 20 min at 10°C,
and stored at -20°C. The conversion from absorbance mea-
sured at 600 nm to the dry cell mass of E. coli BL21 (DE3)
Star™/pAE/LigB (131-645aa) was obtained for the samples
after 4 h induction taken in duplicate, for each 25 mL
bacterial culture. Each pellet was washed three times using
25 mL sterile WFI (water for injection) and centri-
fuged at 18514 × g for at least 30 min. The super-
natant was monitored by absorbance at 600 nm and
discarded when the measure was lower than 0.010. If
the absorbance at 600 nm was higher than 0.010,
another centrifugation was done. A curve with differ-
ent samples from the experimental design was
obtained as g (dry cell)/L = 0.23 Abs600nm (R
2 = 0.93).
Glucose and pH measurements
After 4 h induction, 0.5 mL samples were taken and
centrifuged at 20817 × g for 5 min to separate the cells
(stored at -20°C) from the bacterial culture super-
natant (used for pH and glucose measurements). Ini-
tial pH of TB medium was 7.2 and the final pH of
each culture medium was determined in a potentiom-
eter (Corning). To determine glucose uptake, enzyme
colorimetric assays were used with glucose oxidase(Laborlab commercial kit), using absorbance at 500 nm
and 100 mg/dL standard solution supplied by the manu-
facturer. The samples were diluted at 1:10 in order to
maintain the linearity of the reaction (following manufac-
turer’s instructions, until 450 mg/dL). Glucose concentra-
tions were measured in triplicate, including the standard
solution.
Analysis of expression by SDS-PAGE and densitometry
Cell samples (1 mL) from before induction and at the
end of cultivation under each expression condition from
the experimental design were resuspended in a lysis
buffer (20 mM Tris, 1 mM EDTA, 0.1% Triton X-100,
pH8) to obtain the total protein extracts normalized by
cell growth, at a ratio of 25 μL for each 0.1 of Abs600nm.
Each total extract was disrupted by sonication on ice
during 5 cycles of 10-s pulses with 30-s intervals and 30%
amplitude using an ultrasonic cell disruptor (Sonics &
Material, Inc.), centrifuged at 20,817 × g for 20 min at
10°C and separated into the soluble and insoluble
fractions of the total proteins from recombinant E. coli.
These samples from each condition were run on 12.5%
polyacrylamide gel, stained with Coomassie Blue R-250,
with a marker made up of 2 μg of different proteins
(BSA, 60 kDa; egg albumin, 45 kDa; trypsinogen, 24 kDa;
β-lactoglobulin, 18.4 kDa; and lysozyme, 14.4 kDa), for
the purposes of comparison with bands of a similar
intensity to those of LigB (131-645aa) presented in the
same gel. A curve of different BSA concentrations was
produced using SDS-PAGE to confirm the intensity of the
bands. The areas of the bands corresponding to the
LigB (131-645aa, 54 kDa) expressed under each condition
(total protein and soluble and insoluble fractions) were
analyzed by densitometry using a Bio-Rad GS-800
Calibrated Densitometer and quantified using the
QuantityOne 4.4.1 program by comparing with the stand-
ard marker. The densitometry analyses were undertaken
in duplicate under each of the conditions. For yield and
productivity calculations, only the soluble fraction was
considered. The yield of soluble LigB (131-645aa)
expressed under each condition was obtained using the
equation below, where 4 is the concentration factor
used in the preparation of total protein extract samples:
(mg/L) = (Abs600nm × densitometry band)/4.
Experimental design and statistical analysis
The analysis of the effects of the induction variables
(Absind and IPTG) on the expression of soluble
LigB (131-645aa) in recombinant E. coli BL21 (DE3)
Star™/pAE was performed using a central composite de-
sign containing all the combinations of the two codified
variables at levels -1 (lowest value of the experimental
conditions used), +1 (highest value of the experimental
conditions), and triplicate at 0 (central point condition,
Larentis et al. BMC Research Notes 2014, 7:671 Page 5 of 13
http://www.biomedcentral.com/1756-0500/7/671defined as the intermediate value in the range of each
variable), in order to analyze experimental error and to
check the curvature of the responses. The central points
were run on different days, alongside the other assays, in
order to control and obtain a more realistic assessment
of experimental error. The codification of the levels of
each variable allows the comparison of the importance
of each variable effect, in reference to the evaluated
response.
The significance of each linear coefficient and its inter-
actions was determined using Student’s t-test, at 0.05 prob-
ability level (95% confidence level). The statistical evaluation
of the effects of Absind and IPTG on LigB (131-645aa)
expression was performed with the help of STATISTICA
9.1 software (Statsoft, USA). The fit of the models was
expressed by the correlation coefficients (the closer the
R2 value was to 1, the better it described the experimen-
tal data) and by comparison between the experimental
and model data (calculating the residues and relative
errors for each experiment). The statistical significance
of the model equations for cell growth (g (dry cell)/L)
and expressed LigB (131-645aa) (mg/L and (mg/L)/h)
was checked using the F-test analysis of variance
(ANOVA). The response surfaces were obtained by the
same software as used for the statistical analysis
(STATISTICA).
Expression of LigB protein in microbioreactor
LigB (131-645aa) expression was also performed in
Biopod f800 microbioreactors (Fogale nanotech) using
70 mL culture medium with 1vvm aeration, and modi-
fied polydimethylsiloxane as an anti-foaming agent.
Induction was performed with 0.1 mM IPTG for 4 h,
starting at the end of the exponential phase, as indicated
in the statistical analysis performed in shaking flasks.
The basic parameters for the operation of the micro-
bioreactors followed those described by Frachon et al.
[18].
Protein purification by Immobilized metal affinity
chromatography (IMAC)
Cells grew in microbioreactor were harvested by centri-
fugation at 10,000 × g and resuspended in 20 mM Tris,
1 mM EDTA pH 8.0 and 0.1% Triton X-100. After incu-
bating for 30 minutes at 4°C, the cells were disrupted by
sonication (Sonics & Material). The protein lysate was
centrifuged at 10,000 × g for 20 minutes at 4°C. The re-
covered soluble fraction was applied to a Ni2+-charged
column (Histrap HP, GE Healthcare) in a High pressure
liquid chromatography (HPLC) system and washed with
10 column volumes of buffer (PBS, pH 7.4, 20 mM imid-
azole). The protein was eluted using stepwise gradient of
imidazole varying from 20 mM to 300 mM at 1 mL/min
flow rate. Purified LigB (131-645aa) was checked forhomogeneity, protein quality and amount in a 12.5%
SDS-PAGE by densitometry and quantified by the BCA
method (BCA Thermo Scientific Pierce, Rockford, IL,
USA) according to the manufacturer's recommenda-
tions to determine protein concentration, calculate
yield and relative losses at the different steps. The
procedure was repeated three times for evaluating
reproducibility.Results
Evaluation of pre-induction temperature
The recombinant E. coli BL21 (DE3) Star™/pAE/
LigB (131-645aa) was cultivated at 28°C and 37°C, and
monitored by absorbance at 600 nm every 30 min with a
view to obtaining growth curves for these temperatures
and assessing the specific growth rates at the exponential
phase. It can be seen from Figure 2(a) and the calcula-
tions of specific growth rates at the exponential growth
phases that the maximum growth rate at 28°C (μmax =
0.62 h-1) was around 40% lower than the growth rate
obtained at the optimal E. coli growth temperature of
37°C (μmax = 1.05 h
-1). It took 1 h 50 min to reach ab-
sorbance of 0.75 (early exponential phase) at 37°C,
while it took 3 h to reach the same absorbance at 28°C.
At 37°C, the cell was grown for 4.5 h until reached the
absorbance at 600 nm of around 4, while it took 6 h to
reach this cell growth at 28°C, as shown in Figure 2(a).
At 37°C, μmax of 1.05 h
-1 was maintained until 3 h
growth, at absorbance (measured at 600 nm) of around
2, when cells reach the final exponential growth phase.
In two other runs, the bacteria were cultivated at 28°C
and 37°C until absorbance reached 0.75, at which point
IPTG was added to induce the expression of the recom-
binant protein LigB (131-645aa). In both experiments
the post-induction temperature was kept at 28°C for
4 h, while absorbance was monitored at 600 nm and
the expression level was checked every hour using
SDS-PAGE. In the experiment conducted at 28°C
(both before and after induction with IPTG), a fall of
over 60% in the bacteria growth rate was identified
after induction with IPTG (from 0.62 h-1 to 0.24 h-1)
(Figure 2b). The reduction of the growth rate after
induction may have been caused by the toxic effect
of IPTG and/or the metabolic burden imposed on
the cells due to heterologous gene expression or pro-
tein toxicity [19-24].
When the LigB (131-645aa) expression kinetics at
28°C were compared for the assays using different pre-
induction temperatures (28°C and 37°C), there was
found to be no significant difference between the
growth obtained under the two conditions after induc-
tion with IPTG, nor between the expression levels ob-
tained in 4 h (Table 1).
(a)
(b)

































































28°C (IPTG induced)    
IPTG addition
Figure 2 Growth curves of E. coli BL21 (DE3) Star™/pAE/
LigB (131-645aa). (a) Cell growth at 37°C and 28°C in TB at 200 rpm
(errors in absorbance measured at 600 nm of between 1 and 2%).
(b) Comparison between uninduced and IPTG-induced growth at
28°C. Induction was performed for 4 h after IPTG was added (equivalent
to 7 h process) at Absind = 0.75 (the time when 0.55 mM IPTG was added
is indicated by an arrow at 3 h process). As indicated in the scale, 1 h
induction was reached after 4 h process, 2 h induction after 5 h process,
and 3 h induction after 6 h process, respectively.
Table 1 Comparison of cell growth during 4 h induction
at 28°C (after addition of 0.55 mM IPTG at absorbance
0.75) of E. coli BL21 (DE3) Star™/pAE/LigB (131-645aa)
after two pre-induction growth temperatures, 28°C and
37°C, at 200 rpm in TB medium with the addition of 0.4%



















Induction 0.75 0.76 - -
1 h 1.36 1.40 17 15
2 h 1.69 1.80 80 67
3 h 2.25 2.29 108 118
4 h 2.73 2.97 176 186
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phase was higher at 37°C, the process was initially
conducted at 37°C (optimal temperature for E. coli
growth), and only at the induction phase was the
temperature reduced to 28°C (optimal temperature for
LigB (131-645aa) expression in E. coli). For the evalu-
ation of the effect of IPTG induction at the exponentialphase, the culture took around 3 h at 37°C to reach
absorbance near 2 (highest cell concentration at which
the μmax is kept constant, i.e., the end of the exponen-
tial growth phase). The same absorbance took almost
5 h with growth at 28°C, which would reduce process
productivity.Expression of recombinant LigB using experimental
design to assess cell growth for induction (Absind) and
IPTG concentration
Different experimental conditions were tested to vary the ab-
sorbance for the induction of recombinant LigB (131-645aa)
expression and IPTG concentration, using central composite
design for two variables. E. coli BL21 (DE3) Star™ was culti-
vated at 37°C and 200 rpm until the exponential phase
was reached (Absind of between 0.75 and 2.0), at which
point IPTG (between 0.1 mM and 1 mM) was added
for the expression of recombinant LigB (131-645aa) at
28°C for 4 h.
The bands for the total protein extract, soluble frac-
tion and insoluble fraction analyzed in gel were nor-
malized by cell growth measured by absorbance at
600 nm, as described in Methods. The SDS-PAGE
bands are similar for all the Absind and IPTG concen-
trations tested, indicating that the expression normal-
ized by cell growth did not depend on these variables.
Under all the conditions tested, LigB (131-645aa) was
obtained in its soluble form in the lysis buffer (20 mM
Tris, 1 mM EDTA, 0.1% Triton X-100) with around
15% of the total expressed protein in its insoluble
fraction in all conditions tested, except in assay 4
(at Absind 2.0 and 1 mM IPTG) where the insoluble
fraction was higher, near 35% of the total expressed
protein. The SDS-PAGE analyses undertaken to assess
LigB (131-645aa) expression normalized by cell growth
and solubility by densitometry are shown in Figure 3.
Figure 3 SDS-PAGE with uninduced and IPTG-induced
E. coli BL21 (DE3) Star/pAE/LigB (131-645aa) samples normalized
by absorbance at 600 nm from assay 3 (Absind = 2.0 and IPTG
0.1 mM), total protein extract separated into soluble and
insoluble fractions of recombinant protein in 20 mM Tris/1 mM
EDTA/0.1% Triton X-100 (pH8). Unind = uninduced; Ind = induced;
TE = Total Extract.
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pression in the soluble fraction are shown in Table 2.
In assays 1 and 2, induced at Absind = 0.75, cells grew
for 1 h 45 min and 1 h 50 min, respectively, at 37°C
prior to induction; cells grew for 2 h 45 min and 3 h in
assays 3 and 4 (Absind = 2.0), respectively. At the central
points, cells grew for 2 h 15 min for absorbance to reach
1.4 each. These cell growth times in each experimentTable 2 Results for cell growth (measured by absorbance at 6
(DE3) Star™/pAE/LigB (131-645aa), yield (mg/L) and productiv
expressed in shaking flasks at 28°C for 4 h in TB using centra
induction) with triplicate at the central point (CP)









1 5.75 0.75 (-1) 0.1 mM (-1) 3.75 0.9 0.94 (-4
2 5.83 0.75 (-1) 1.0 mM (+1) 3.31 0.8 0.74 (7.
3 6.75 2.0 (+1) 0.1 mM (-1) 6.33 1.6 1.54 (3.
4 7.00 2.0 (+1) 1.0 mM (+1) 5.19 1.3 1.34 (-3
CP 1c 6.25 1.4 (0) 0.55 mM (0) 4.83 1.2 1.14 (5.0
CP 2 6.25 1.4 (0) 0.55 mM (0) 4.46 1.1 1.14 (-3
CP 3 6.25 1.4 (0) 0.55 mM (0) 4.53 1.1 1.14 (-3
aTotal process time = growth time + 4 h induction. The growth time varied accordin
IPTG and induction of LigB (131-645aa).
bModel response obtained for each variable with its relative error in parenthesis (%
cCP is the central point, calculated as the intermediate condition between the infer
design procedures.
The calculated errors were lower than 12%.prior to the addition of the inducer were added to the
4 h induction time for the productivity calculations
shown in Table 2.
With regard to the cell growth at which LigB (131-645aa)
was to be induced, there was found to be a significant
increase in cell growth and recombinant protein
expression when Absind 0.75 was compared with 2.0,
while the IPTG concentration was kept the same
(Table 2). In assays 1 and 3, where induction was
done at 0.75 and 2.0, respectively, and the IPTG
concentration was the same (0.1 mM), cell growth of
0.95 and 1.6 g (dry cell)/L was obtained (respectively
3.75 and 6.33 in terms of absorbance at 600 nm)
while 180 mg/L and 288 mg/L LigB (131-645aa) was
expressed, representing around 70% higher cell growth
and 60% higher protein expression. When assays 2 and
4 are compared, where induction with 1 mM IPTG
was made at different absorbances, cell growth and
LigB (131-645aa) expression were also found to be
higher when the Absind was higher. When the concen-
tration of inducer was varied, the comparison of assays
1 and 2 (Absind 0.75) and the comparison of assays 3 and
4 (Absind 2.0) show that cell growth and LigB (131-645aa)
expression were both higher at 0.1 mM (Table 2), although
the difference was lower than when the cell concentration
was varied at induction. The productivity data (amount of
expressed target protein per volume of bacterial culture
per process time) indicated that at the lower concentration
of IPTG (0.1 mM), expressing the target protein at Absind
2.0 was better.00 nm and converted to g (dry cell)/L) of E. coli BL21
ity ((mg/L)/h) of soluble recombinant LigB (131-645aa)
l composite design for two variables (Absind and IPTG for













.4%) 180 177 (2%) 31.3 31.2 (0.4%) 6.64 6.4
5%) 166 163 (2%) 28.4 28.4 (0.1%) 6.75 6.8
8%) 288 286 (1%) 42.7 42.6 (0.2%) 6.36 5.2
.1%) 221 218 (1%) 31.5 31.4 (0.5%) 6.24 5.1
%) 198 211 (-7%) 31.7 33.4 (-5.4%) 6.63 6.4
.6%) 214 211 (1%) 34.2 33.4 (2.4%) 6.53 5.8
.6%) 210 211 (-1%) 33.6 33.4 (0.6%) 6.55 5.1
g to the time each culture took to reach the Absind required for the addition of
= ((experimental data - predicted by model)/experimental data) x 100).
ior (-1) and superior levels (+1) and coded as 0, according to experimental
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(Absind = 1.4 and 0.55 mM IPTG), the errors associated
with each of the response variables were assessed by
calculations of means and their respective standard
deviations, resulting in 1.15 ± 0.05 g (dry cell)/L for cell
growth (equivalent of 4.61 ± 0.20 measured by absorb-
ance at 600 nm), and 207 ± 8 mg/L for the yield of sol-
uble LigB (131-645aa) expressed, while productivity
was found to be 33.2 ± 1.3 (mg/L)/h. The errors calcu-
lated for the intermediate Absind and IPTG conditions,
in triplicate (Central Points 1-3), were lower than 5%.
The errors in the data obtained from the densitometry
analysis that were used to calculate protein expression
were found to be around 8%.
There was no significant reduction in the pH at the
end of the experiments, as they were buffered with po-
tassium salts in the TB medium (Table 2). The final pH
at the central points was measured at around 6.6 ± 0.1
(errors of less than 1%). The glucose uptake after the
4 h induction period was found to be 30-50% of the ini-
tial concentration (9-10 g/L confirmed by the enzyme
colorimetric method used) (Table 2). This indicates
that the initial glucose concentration could have been
lower. The assessment of the central point indicated
the error in the glucose measurements to be around
12%, averaging 5.8 ± 0.7 g/L. The experiments that re-
sulted in the greatest drop in pH and the greatest glu-
cose uptake were the ones that yielded the highest cell
growth.
Experimental design techniques were developed so
that the maximum of process information could be
gathered using the smallest number of experiments.
Experimental design techniques usually rely on em-
pirical model structures in order to interpret experi-
mental data and provide optimal process operation
conditions [23]. The linear effects and the effect of
the interaction between Absind and IPTG concentra-
tion (x1 and x2 for codified variables, respectively) on
cell growth (in g (dry cell)/L), the yield of expressed
soluble LigB (131-645aa) (mg/L) and productivity
((mg/L)/h) can be described by linear models ob-
tained by the statistical analysis with 95% confidence
level (p < 0.05 for statistically significant parameters),
according to the equations below (in terms of codi-
fied variables):g dry cellð Þ = L ¼ 1:14  0:02ð Þ þ 0:3  0:02ð Þx1 þ
mg LigB=L ¼ 211:0  3:2ð Þ þ 40:8  4:2ð Þx1 þ − 2ð
mg LigB=Lð Þ=h ¼ 33:4  0:4ð Þ þ 3:6  0:6ð Þx1 þ −ðExperimental and model data for each experiment
were compared in order to check if the models are real-
ist (shown in Table 2). The relative errors confirmed the
models were representative of the experimental data.
The correlation coefficients (R2) obtained were around
0.98 and Fcal> > Ftab in the F-test analysis of variance
(ANOVA), shown in Table 3, indicating that the models
are statistically significant and predictive.
The models were evaluated by the correlation coefficients
R2 and ANOVA, demonstrating that they represent the ex-
perimental data (good agreement between the experimental
values and the values predicted by the models); as such, the
response surfaces could be obtained from themodels. The re-
sponse surfaces for cell growth and soluble LigB (131-645aa)
productivity can be seen in Figure 4, where the linear effects of
Absind and IPTG and the effect of their interactions on the
response variables can be assessed.
The models indicate that the growth of E. coli BL21
(DE3) Star™/pAE/LigB (131-645aa) (measured by absorb-
ance at 600 nm and converted to g (dry cell)/L), the yield of
soluble protein (mg/L) at the end of 4 h induction and the
productivity of the process taken as a whole, in (mg/L)/h,
were influenced both by the cell growth at which protein
expression was induced by IPTG, and by the concentration
of the inducer. It was also found that the interaction
between the two variables, Absind and IPTG, had a signifi-
cant effect on soluble LigB (131-645aa) expression: the
concentration of IPTG that yielded increased protein pro-
duction depended on the cell growth when induction was
begun. The interaction between these two variables did not
have a statistically significant effect only on cell growth,
since p > 0.05 for this parameter. The statistical analysis for
the densitometry values of the bands corresponding to the
soluble fractions in SDS-PAGE (that means the soluble
expression of LigB (131-645aa) normalized by cell growth)
indicated that both Absind and IPTG concentration had no
statistical influence on this response, as all the effects
resulted in p > 0.05.
The data on soluble LigB (131-645aa) expression indi-
cated that productivity was improved when 0.1 mM
IPTG was used (lower inducer concentration) and when
the highest absorbances were reached for induction at
the final exponential growth phase, keeping the max-
imum specific growth rates (Absind 2.0). Induction at
Absind 2.0 resulted in a higher level of expression of the−0:1  0:02ð Þx2 R2 ¼ 0:98
 
0:4  4:2Þx2 þ −13:3  4:2ð Þx1x2 R2 ¼ 0:98
 
3:5  0:6Þx2 þ −2:1  0:6ð Þx1x2 R2 ¼ 0:97
 
Table 3 Analysis of variance (ANOVA) for g (dry cell)/L,
mg/L and (mg/L)/h responses for soluble LigB (131-645aa)
expression
Response R2 a Fcalculated
b Ftabulated
c
g (dry cell)/L 0.98 55.3 6.94
mg LigB/L 0.98 43.4 9.28
(mg LigB/L)/h 0.97 32.3 9.28
aR2 = SSModel/SSModel + Residues,
bFcal =MSModel/MSResidues,
cFtab = F 0.05%, df Model, df Residues.
MS = SS/df where MS =mean squares, SS = sum of squares and df = degrees
of freedom.
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soluble LigB (131-645aa) expression yield and productivity).
Comparing with the assay when Absind was 0.75 (early ex-
ponential phase) and IPTG was 1 mM, cell growth in-
creased by almost 100% while soluble LigB (131-645aa)(b)
(a)
Figure 4 Model representation for the effects of Absind and
IPTG on (a) cell growth measured at 600 nm (Abs600nm) and
(b) LigB (131-645aa) productivity ((mg/L)/h) in E. coli BL21
(DE3) Star™/pAE.expression rose by around 50%, even though the process
time was increased because induction was done at a higher
absorbance at the exponential phase. The IPTG concen-
tration was reduced to the lowest value because had a
negative effect on cell growth, the final yield of soluble
LigB (131-645aa) obtained, and the overall productivity of
the process. The data therefore indicated that the best
concentration of IPTG for expression was 0.1 mM.
The condition that produced the higher yield and prod-
uctivity of soluble LigB (131-645aa) in E. coli BL21 (DE3)
Star™/pAE was confirmed in shaking flasks by inducing
protein expression at the final exponential growth phase
using the minimum inducer concentration. The expression
results for the triplicate in shaking flasks at Absind 2.0 and
0.1 mM IPTG (equivalent to assay 3 presented in Table 2),
28°C, for 4 h induction in TB medium were: 1.5 ± 0.1 g
(dry cell)/L (equivalent to 5.9 ± 0.4 measured by absorb-
ance at 600 nm) for cell growth, yield of 272 ± 6 mg/L for
LigB (131-645aa) expression, and 40.4 ± 0.9 (mg/L)/h for
productivity.Correlation between cellular growth and protein
expression yield
In order to check whether the expression of soluble
LigB (131-645aa) was proportional to cell growth, a
linear correlation was performed using the experi-
mental design results (Figure 5). The equation:
mg/L = 181 (g dry cell)/L, with a linear correlation coef-
ficient (R2) of 0.9, was obtained, indicating that the soluble
expressed LigB (131-645aa) was proportional to cell





























Cell concentration (g dry cell mass/L)  
E. coli BL21 (DE3) Star / pAE / LigB (131-645aa)
Figure 5 Correlation between soluble LigB (131-645aa) expression
(mg/L) in E. coli BL21 (DE3) Star™/pAE and cell growth measured at
600 nm (Abs600nm). The linear correlation is mg/L = 181 (g dry cell)/L or
mg/L = 45.3 Abs600nm, that is, (mg L
-1)/Abs600nm = 45.3 = YP/X.
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liter of culture at Abs600nm of 1, the yield factor was
45.3 mg/L per absorbance measured at 600 nm, which
indicates the same significance as the yield of product
per unit of cell [25]. This finding indicates that the ex-
pression of soluble LigB (131-645aa) in the conditions
tested in this work in terms of mg L−1 Abs−1 was simi-
lar in all the experiments, with an error of around 10%.
That is, LigB (131-645aa) expression per cell in terms
of mg L−1 Abs−1 obtained from the bands of the soluble
fractions in the densitometry analysis was not statisti-
cally influenced by either of the variables (Absind and
IPTG concentration), as already indicated before.Figure 6 SDS-PAGE results from protein purification obtained
with 300 mM imidazole elution by IMAC. The lysate fraction
contains 25-27% LigB (131-645aa) and flow-through contains
proteins without binding, leading to enrichment of the protein of
interest in the last gel lane.Expression of LigB protein in microbioreactor and
purification by IMAC
The condition for soluble LigB (131-645aa) expression at
the end of exponential growth phase and 0.1 mM IPTG
was also performed using Biopod microbioreactors. A cell
growth curve was run in the Biopod microbioreactors at
37°C in TB medium without induction of E. coli BL21
(DE3) Star™/pAE/LigB (131-645aa) and the exponential
phase was reached after 1 h, corresponding to an absorb-
ance at 600 nm of 6. The exponential growth phase was
verified until the absorbance of 12 and the final absorb-
ance was around 18 after 6.5 h. This growth was due to
high rate of aeration caused by the dispersion of air
through microbubbles [18].
The maximum specific growth rate at 37°C (μmax de
0.69 h-1) was maintained until the bacteria reached ab-
sorbance 12. At this point, the cells were induced with
0.1 mM IPTG, as suggested by the experimental design
performed in shaking flasks. The specific growth rate
of the bacteria was found to be 0.3 h-1 after induction
with IPTG at 28°C (25% improvement over the specific
growth rate of 0.24 h-1 obtained in shaking flasks). Cell
grew until 18.8 ± 1.2 (measured by absorbance at
600 nm) after 4 h induction. The results for densitometry
of soluble protein bands showed a yield of 970 ± 174 mg/L
and a final productivity of 157.4 ± 28.2 (mg/L)/h. The
soluble fraction of the protein was around 77% of the total
LigB (131-645aa) expressed in this condition. Cell growth,
expression levels and productivities were greater than in
shaking flasks due to more efficient aeration in the micro-
bioreactor [18].
Protein purification was performed by IMAC and
eluted with 300 mM imidazole, as shown in Figure 6.
LigB (131-645aa) band evaluated by gel densitometry
was equivalent to 25-27% of the total E. coli protein
lysate obtained in microbioreactor (Figure 6). Purified
LigB (131-645aa) was obtained in a final concentration
of 260 mg/L medium culture with 91% homogeneity
(10% error).Discussion
With a view to increasing the yield and productivity of
the rapid diagnostic test for leptospirosis under valid-
ation at Bio-Manguinhos/Fiocruz, experimental design
was used to assess the expression of soluble recombin-
ant LigB (131-645aa) using pAE in E. coli BL21 (DE3)
Star™ in shaking flasks and in microbioreactors. From
an industrial point of view, cell stocks were controlled
by CFU counting to avoid the influence of different vi-
able cells on the expression experiments, because they
were performed in different days. This is not usually
evaluated, or at least not reported in the literature, but
it is essential to avoid it became a source of errors/
variability beyond the acceptable levels in the production
process.
Concerning the influence of pre-induction temperature,
no significant difference was found in the results for cell
growth or soluble LigB (131-645aa) expression for the ex-
periments run at the two different conditions tested (28°C
and 37°C), followed by induction of the recombinant pro-
tein at 28°C. Similar results showing that the temperature
at the pre-induction process phase did not influence re-
combinant protein expression were also described by
Islam et al. [26]. Shin et al. [27] also reported a lack of any
correlation between the pre-induction specific growth rate
and the recombinant protein synthesis for different pro-
teins in recombinant E. coli cultures. In our research
group, the same conclusion was reached for the expres-
sion of another LigB construction comprising only do-
mains 7 to 11 of the protein, corresponding to 40 kDa
(Figure 1) in pET100-D/TOPO in the same host cell (data
not shown). Nevertheless, the relationship depends on the
characteristics of the particular recombinant system: the
promoter system, host-vector interaction, the toxicity of
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induction temperature on the expression of some recom-
binant proteins after induction have also been reported in
the literature [25,27].
As such, the strain was cultivated at 37°C until IPTG
was added, while induction was conducted at 28°C,
thereby reducing the overall process time. Under this
condition, LigB (131-645aa) expression was assessed
using central composite design for two variables: cell
growth at which the expression was induced (absorbance
at 600 nm of between 0.75 and 2.0) and the concentra-
tion of the inducer in the recombinant system (varying
from 0.1 to 1 mM IPTG). Induction at the highest ab-
sorbance at the exponential phase while keeping the spe-
cific growth rate at its maximum resulted in higher
yields of cell growth and soluble protein expressed. The
obtained linear models indicated that higher expression
of the recombinant protein could be achieved using
higher absorbances than 2.0 for later induction time.
However, higher absorbances were not tested because
process time would be increased when conducting the
batches to higher times than the corresponding work
shift of the technicians in the factory and this should be
taken into consideration when making an economic
evaluation of the process.
Meanwhile, a higher IPTG concentration had a negative
effect on cell growth and on soluble LigB (131-645aa) yield
and productivity, as described for other recombinant sys-
tems [21,26,28-33]. Because of the negative effect of IPTG,
the common strategy of using IPTG at an untested
pre-determined concentration for inducing recombinant
E. coli can result in the process being performed under
non-optimal conditions, reducing cell and protein yields
[28,30]. The data obtained using experimental design tools
indicate that in the shaking flasks it was suitable to use an
inducer concentration that was ten times smaller than the
“standard” concentration of 1 mM usually employed in
molecular biology [14,24], resulting in reduced damage on
cell growth and increased soluble LigB (131-645aa) ex-
pression, while also keeping IPTG at its lowest and most
economical level. Reducing the IPTG concentration is also
attractive from an industrial point of view because it is an
expensive compound and is potentially toxic [19,20], and
high IPTG concentrations can lead to a severe reduction
in the growth rate of some recombinant E. coli (especially
when toxic proteins are produced) or to the expression of
some proteases, reducing the yield of recombinant pro-
teins [28-30]. However, the establishment of an optimal
inducer concentration is essential for the expression of
heterologous proteins, since low concentrations may fail
to achieve full induction [29].
Based on the scale of E. coli growth in shaking flasks,
the minimal level of IPTG tested (0.1 mM) was enough to
induce the expression of recombinant LigB (131-645aa),as described for other proteins and verified in other
works by our research group, and often have no de-
trimental effect on recombinant protein expression
[31-39]. However, for high cell density cultures in bio-
reactors, the IPTG concentration should be adjusted
to the higher cell levels obtained, although care should
be taken to prevent raising the concentration too high
because of its toxic effect on the cells. Even if part of
the expressed protein was insoluble with increase of
the IPTG concentration, as was the case when expres-
sion took place at a higher absorbance at the exponen-
tial phase with 1 mM IPTG in shaking flasks, growth
at high cell densities is essential to provide increasing
heterologous protein production.
As growth in shaking flasks is limited by the low oxy-
gen transfer rate, the obtainment of high cell densities in
a bioreactor, enabling a higher yield of cell mass, is es-
sential for establishing a process with a greater final yield
of soluble protein. Urban et al. [29] note that the limited
solubility of the expressed product may be partially off-
set by the accumulation of cells; taken together, these
two factors determine optimal expression conditions.
Ultimately, the experimental condition that yields an op-
timal response should consider both cell growth and
genetic factors (mRNA and metabolic synthesis and deg-
radation of the protein) in order to enhance expression
of the heterologous protein. Islam et al. [26] and Urban
et al. [29] discuss that the highest soluble protein yields
are obtained under conditions which promote both a
slow growth rate during protein synthesis and a high
final cell mass yield.
It was found that the expression of soluble
LigB (131-645aa) in shaking flasks using the pAE system
was proportional to cell growth in E. coli BL21 (DE3)
Star™. As discussed in the literature, the level of intracel-
lular accumulation of a recombinant protein depends on
the final cell growth and the specific productivity of the
protein, with the level of accumulation being relative to
total protein [22]. The proportionality of heterologous
protein production and cell mass is also shown by the
experimental findings of Sunitha et al. [40], since the
amount of phytase from Bacillus sp. DS11 produced by
lactose induction under the control of a strong T7 pro-
moter was proportional to E. coli BL21 (DE3) mass.
However, this is not always the case, as shown in the
works of Nikerel et al. [41,42] involving the expression
of TaqI restriction endonuclease in E. coli under the
control of a strong T7 RNA polymerase promoter.
Also, the results of the expression of a soluble viral
structural protein from murine polyomavirus in E. coli
in terms of normalized expression level in mg.L−1.Abs−1
(milligrams per liter of culture at Abs600nm of 1), were
not the same for the different conditions tested by
Chuan et al. [25].
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Induction at Absind 2.0 and 0.1 mM IPTG, 28°C, for 4 h
in TB medium in shaking flasks produced 270 mg/L of
soluble LigB (131-645aa). In microbioreactors, the in-
duction was performed at the end of exponential phase
(Absind 11-12), under which condition 970 mg/L of sol-
uble LigB (131-645aa) was obtained, which is compatible
with results obtained in works that evaluate the expression
of other recombinant proteins in E. coli [28,30,35-38]. The
best strategy for obtaining higher protein yields was found
to be growth at high cell densities, since the process is de-
termined by cell growth; therefore, the growth using high
cell densities in microbioreactors with induction at the
end exponential phase with lower IPTG concentrations
showed better results for protein expression, achieving
350% increase. Thanks to experimental design, it was pos-
sible to assess the effects and interactions of the induction
variables on the expression of soluble LigB (131-645aa),
with a view to improving the productivity of the process
and reducing the production costs of a rapid test for the
efficient diagnosis of leptospirosis. These results highlights
the importance of using experimental design tools to avoid
taking a simplistic approach that considers each variable
as being independent.
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